# Final Production Recommendation (Engine 70)

Date: 2026-08-01. This document synthesizes every certification artifact
produced across this session's full program -- the original G01-G10
launch gate work, the G04/G05 implementation rounds, Batch 4's end-to-end
workflow certification, Engine 51's merge readiness audit, and this
batch's ten enterprise governance documents -- into a single verdict.
It does not supersede `docs/release/rc1-ga/GA_DECISION.md` (still
authoritative for General Availability) or `FINAL_GO_NO_GO.md` (still
authoritative for the detailed pilot go/no-go reasoning); it restates
their conclusions at the executive level this program's final document
is expected to provide, and confirms nothing discovered in Batch 7
changes either verdict.

## Verdict: GO WITH CONDITIONS for a controlled pilot; NO-GO for General Availability

This is not a new decision -- it is this document's confirmation that
`FINAL_GO_NO_GO.md`'s NO-GO (with a named, four-item closable path) and
`GA_DECISION.md`'s NO-GO (blocked on items outside repository control)
both still hold after this batch's governance review. **"GO WITH
CONDITIONS"** here means: the codebase is architecturally and clinically
sound enough that closing four specific, already-diagnosed items
converts the pilot verdict to GO -- it does not mean the pilot can start
today.

## What is certified GO, unconditionally, as of this document

- **Architecture**: `ARCHITECTURE_CONFORMANCE_FINAL.md` -- the MVP
  Constitution's runtime-profile model is followed everywhere it applies;
  no route bypasses its Application-class boundary
  (`architecture.test.ts`, enforced and demonstrated catching a real
  violation this session).
- **RBAC and audit**: `SECURITY_GOVERNANCE_REPORT.md`'s "not a finding"
  section -- 100%-covered, independently re-enforced at every layer, no
  gap identified anywhere in this program's review.
- **Clinical governance**: `CLINICAL_GOVERNANCE_REPORT.md` -- no
  automated system can make or bypass a clinical decision; every decision
  is attributed, traceable, and (with the one named `clinical_findings`
  exception) tamper-evident.
- **Tenant isolation, in source**: 57 tenant tables statically verified
  RLS-enabled with policies (`rls-matrix.test.ts`); the isolation model
  itself is sound. What is not certified is live proof (see below).
- **Migration and change discipline**: append-only migrations, CI-gated
  `npm run check`/`npm run build`, ADR-gated frozen-contract changes --
  all real, all demonstrated multiple times this session.

## What blocks GO today, and the exact path to close it

Unchanged from `FINAL_GO_NO_GO.md`, reconfirmed by this batch's
`EXECUTIVE_RISK_REVIEW.md`:

1. Provision one live Supabase test environment (closes both Critical
   security/concurrency risks in a single action).
2. Close the WhatsApp -> WF-003 chaining gap (wiring, not new capability
   -- both sides already exist and are individually certified).
3. Build the minimum G09 slice (one real notification channel,
   WhatsApp, plus wiring `OutboxDispatcher` to one real event).
4. Rotate the two historical leaked credentials (independent action,
   should not wait on the others).

No item on this list requires new architecture, a new ADR, or scope
expansion -- all four are extensions of work this program has already
certified in source.

## What is explicitly NOT required before a pilot (do not add scope)

Restated from `FINAL_GO_NO_GO.md`, unchanged: OCR, the full
`needs_information` clarification round-trip (binary approve/reject is
an acceptable interim posture for a small, briefed pharmacist cohort,
pending the clinical-leadership sign-off `CLINICAL_GOVERNANCE_REPORT.md`
flags), `clinical_findings` immutability (real gap, low urgency at pilot
scale), full G09, and every GA-specific item `GA_DECISION.md` owns
(managed backup/DR exercises, independent penetration test, provider
conformance attestations, human sign-offs).

## What remains genuinely undecided, requiring a human, not an engineer

Per `EXECUTIVE_RISK_REVIEW.md`'s organizational/policy category: pharmacist
licensure verification (assumed external, unevidenced in this system),
patient consent/disclosure language for AI-flagged findings, prescription-
image retention/deletion policy, and data-subject deletion request
handling. None of these block a controlled pilot per `FINAL_GO_NO_GO.md`'s
explicit scoping, but all four need an owner and a decision before wider
rollout, and none can be resolved by further engineering certification
work -- they need policy, legal, or clinical-leadership sign-off.

## Confidence basis

This recommendation is evidence-based, not aspirational: every claim
above traces to a specific document, test, or migration cited within it,
and every open item is stated as Blocked-with-named-dependency rather
than assumed complete, consistent with this entire program's discipline.
No PASS was fabricated in the absence of evidence at any point across
this session's ten-plus certification documents; where evidence could
not be gathered without live infrastructure, that limitation is stated
explicitly rather than papered over.

## Recommendation to the repository owner

1. **Do not open PR #10 or start new feature work** until PR #5-#9 are
   reviewed and merged (per the standing RC1 Integration Freeze
   instruction) and this batch's governance documents are reviewed.
2. **Execute the four-item closable path** as the very next engineering
   priority -- it is the shortest path from NO-GO to GO for a pilot, and
   every item is already fully scoped by this program's own documents.
3. **Route the four organizational/policy questions** to the appropriate
   human owners (clinical leadership, legal/compliance, product) in
   parallel with the engineering path -- they do not block the pilot
   decision per `FINAL_GO_NO_GO.md`, but they should not be left
   undecided indefinitely either.
4. **Treat this program's ten documents as a governance baseline**, not
   a one-time exercise -- `CONTINUOUS_IMPROVEMENT_FRAMEWORK.md` names the
   concrete mechanism (diff future reviews against this baseline, not
   rewrite from scratch) for keeping it current as RC1 moves toward pilot
   and eventually GA.

## Verdict, restated in one line

**MedLink's engineering foundation is sound and ready for a controlled
pilot once four already-scoped, non-architectural items are closed; it
is not ready today, and General Availability remains correctly gated on
items outside this repository's control.**
